Q2 2023 13F Holders as of 30 Jun 2023
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
123,850,680
-
Number of holders
-
293
-
Total 13F shares, excl. options
-
110,144,879
-
Shares change
-
+17,906,482
-
Total reported value, excl. options
-
$3,943,258,288
-
Value change
-
+$694,610,966
-
Put/Call ratio
-
79%
-
Number of buys
-
173
-
Number of sells
-
-130
-
Price
-
$35.80
Significant Holders of Guardant Health, Inc. - Common Stock (GH) as of Q2 2023
368 filings reported holding GH - Guardant Health, Inc. - Common Stock as of Q2 2023.
Guardant Health, Inc. - Common Stock (GH) has 293 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 110,144,879 shares
of 123,850,680 outstanding shares and own 89% of the company stock.
Largest 10 shareholders include VANGUARD GROUP INC (10,803,328 shares), BlackRock Inc. (9,677,521 shares), FMR LLC (8,802,546 shares), ALLIANCEBERNSTEIN L.P. (4,463,669 shares), PRICE T ROWE ASSOCIATES INC /MD/ (4,215,380 shares), EVENTIDE ASSET MANAGEMENT, LLC (4,008,602 shares), Temasek Holdings (Private) Ltd (3,963,872 shares), Capital International Investors (2,895,044 shares), Point72 Asset Management, L.P. (2,714,285 shares), and MILLENNIUM MANAGEMENT LLC (2,434,178 shares).
This table shows the top 293 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.